Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-034808
Filing Date
2025-03-06
Accepted
2025-03-06 16:45:27
Documents
100
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K avir-20241231.htm   iXBRL 10-K 3186496
2 EX-10.1(5) avir-ex10_15.htm EX-10.1(5) 69251
3 EX-10.1(6) avir-ex10_16.htm EX-10.1(6) 68575
4 EX-19.1 avir-ex19_1.htm EX-19.1 145473
5 EX-21.1 avir-ex21_1.htm EX-21.1 7096
6 EX-23.1 avir-ex23_1.htm EX-23.1 4564
7 EX-31.1 avir-ex31_1.htm EX-31.1 18225
8 EX-31.2 avir-ex31_2.htm EX-31.2 18080
9 EX-32.1 avir-ex32_1.htm EX-32.1 10729
10 EX-32.2 avir-ex32_2.htm EX-32.2 11088
11 GRAPHIC img58515982_0.jpg GRAPHIC 132647
12 GRAPHIC img58515982_1.jpg GRAPHIC 107982
13 GRAPHIC img58515982_2.jpg GRAPHIC 406523
14 GRAPHIC img58515982_3.jpg GRAPHIC 281328
15 GRAPHIC img58515982_4.jpg GRAPHIC 61201
16 GRAPHIC img58515982_5.jpg GRAPHIC 54584
17 GRAPHIC img58515982_6.jpg GRAPHIC 33362
18 GRAPHIC img58515982_7.jpg GRAPHIC 38613
19 GRAPHIC img58515982_8.jpg GRAPHIC 53712
  Complete submission text file 0000950170-25-034808.txt   14616497

Data Files

Seq Description Document Type Size
20 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT avir-20241231.xsd EX-101.SCH 1373048
103 EXTRACTED XBRL INSTANCE DOCUMENT avir-20241231_htm.xml XML 1946866
Mailing Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110
Business Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Filer) CIK: 0001593899 (see all company filings)

EIN.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39661 | Film No.: 25715954
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)